全文获取类型
收费全文 | 5924篇 |
免费 | 236篇 |
国内免费 | 67篇 |
专业分类
耳鼻咽喉 | 181篇 |
儿科学 | 314篇 |
妇产科学 | 228篇 |
基础医学 | 409篇 |
口腔科学 | 286篇 |
临床医学 | 608篇 |
内科学 | 1441篇 |
皮肤病学 | 82篇 |
神经病学 | 325篇 |
特种医学 | 256篇 |
外科学 | 1195篇 |
综合类 | 112篇 |
预防医学 | 137篇 |
眼科学 | 233篇 |
药学 | 218篇 |
中国医学 | 5篇 |
肿瘤学 | 197篇 |
出版年
2024年 | 5篇 |
2023年 | 55篇 |
2022年 | 75篇 |
2021年 | 115篇 |
2020年 | 86篇 |
2019年 | 132篇 |
2018年 | 139篇 |
2017年 | 128篇 |
2016年 | 149篇 |
2015年 | 196篇 |
2014年 | 212篇 |
2013年 | 286篇 |
2012年 | 400篇 |
2011年 | 375篇 |
2010年 | 235篇 |
2009年 | 211篇 |
2008年 | 465篇 |
2007年 | 521篇 |
2006年 | 497篇 |
2005年 | 435篇 |
2004年 | 348篇 |
2003年 | 290篇 |
2002年 | 226篇 |
2001年 | 121篇 |
2000年 | 113篇 |
1999年 | 108篇 |
1998年 | 46篇 |
1997年 | 41篇 |
1996年 | 36篇 |
1995年 | 19篇 |
1994年 | 27篇 |
1993年 | 14篇 |
1992年 | 12篇 |
1991年 | 20篇 |
1990年 | 16篇 |
1989年 | 15篇 |
1988年 | 10篇 |
1987年 | 7篇 |
1986年 | 4篇 |
1985年 | 5篇 |
1984年 | 4篇 |
1983年 | 3篇 |
1981年 | 6篇 |
1980年 | 6篇 |
1977年 | 2篇 |
1975年 | 1篇 |
1973年 | 1篇 |
1971年 | 3篇 |
1970年 | 2篇 |
1969年 | 1篇 |
排序方式: 共有6227条查询结果,搜索用时 15 毫秒
1.
2.
3.
Targeting in a cellular level is still one of the major challenges in biomedical treatments. However, new synthetic and analytical techniques now allow the development of precisely prepared macromolecules. Thus, glycopolymer chains are reported to be prepared with controlled length, monomer sequences, as well as chain‐folded structures. A high level of complexity in synthetic macromolecules also allows increased selectivity in targeting, which is a key factor in biomedical applications. 相似文献
4.
5.
Formulation and in Vitro-in Vivo Evaluation of Sustained-Release Lithium Carbonate Tablets 总被引:1,自引:0,他引:1
Çiftçi Kadriye Çapan Yilmaz Öztürk Orhan Hincal A. Atilla 《Pharmaceutical research》1990,7(4):359-363
The release of lithium carbonate incorporated into polymethylmethacrylate, poly vinyl chloride, hy-drogenated vegetable oil, and carbomer matrix tablets was studied in vitro. The formulation containing 10% carbomer showed a sustained-release profile comparable to that of a standard, commercially available, sustained-release preparation containing 400 mg lithium carbonate embedded in a composite material. In vivo the newly formulated and standard sustained-release lithium carbonate tablets were compared to an oral solution and conventional lithium carbonate tablets in 12 healthy subjects. These crossover studies showed that the sustained-release tablets produced a flatter serum concentration curve than the oral solution and conventional tablet, without loss of total bioavailability. 相似文献
6.
7.
8.
Z Yilmaz T Renton Y Yiangou J Zakrzewska I P Chessell C Bountra P Anand 《Journal of clinical neuroscience》2007,14(9):864-871
Burning mouth syndrome (BMS) is often an idiopathic chronic and intractable pain condition, affecting 1.5-5.5% of middle-aged and elderly women. We have studied the heat and capsaicin receptor TRPV1, and its regulator nerve growth factor (NGF), in BMS. Patients with BMS (n=10) and controls (n=10) were assessed for baseline and post-topical capsaicin pain scores, and their tongue biopsies immunostained for TRPV1, NGF, and structural nerve markers neurofilament and peripherin. Nerve fibres penetrating the epithelium were less abundant in BMS (p<0.0001), indicating a small fibre neuropathy. TRPV1-positive fibres were overall significantly increased in BMS (p=0.0011), as were NGF fibres (p<0.0001) and basal epithelial cell NGF staining (p<0.0147). There was a significant correlation between the baseline pain score and TRPV1 (p=0.0143) and NGF fibres (p=0.0252). A significant correlation was observed between baseline and post-capsaicin pain (p=0.0006). Selective TRPV1 and NGF blockers may provide a new therapy for BMS. 相似文献
9.
10.
Ittel TH; Steinhausen C; Kislinger G; Kinzel S; Nolte E; Sieberth HG 《Nephrology, dialysis, transplantation》1997,12(7):1369-1375
BACKGROUND: Developments in accelerator mass spectrometry (AMS) now permit
the determination of femtogram amounts of 26Al in blood and in various
tissues with good precision and free of external contamination. METHODS: In
the present study we used trace quantities of 26Al to investigate the
intestinal absorption and compartmentalization of aluminium in rats with
renal failure (Nx, 5/6 nephrectomy) and in pair- fed controls (C). Single
oral doses of 20 ng 26Al were administered to six animals in each group
and, subsequently, 24-h post-load 26Al was analysed in serum, urine, bone,
liver, and spleen by means of AMS. RESULTS: Serum concentrations of 26Al
were significantly lower in uraemic rats compared to controls, whereas
urinary excretion was comparable (Nx, 7.11 +/- 5.78 pg/day vs C, 9.46 +/-
6.10 pg/day), suggesting a higher fraction of ultrafiltrable serum 26Al in
uraemia. The target tissues of cellular transferrin-mediated 26Al uptake,
liver and spleen, tended to show a larger degree of aluminium accumulation
in controls (0.26 +/- 0.31 pg/g vs Nx, 0.14 +/- 0.10 pg/g and 0.37 +/- 0.27
pg/g vs Nx, 0.25 +/- 0.27 pg/g respectively). In contrast, in bone, a site
of extracellular aluminium deposition, 26Al concentrations were more
elevated in uraemia (1.22 +/- 0.59 pg/g vs C: 0.68 +/- 0.30 pg/g).
Estimated total 26Al accumulation in all measured target tissues was
significantly higher in uraemic rats (28.15 +/- 9.90 pg vs C: 17.03 +/-
7.03 pg) and total recovery of 26Al from tissue and urine was 26.58 +/-
6.74 pg in controls and 35.75 +/- 7.03 pg in uraemic animals, suggesting a
fractional absorption of 0.133% and 0.175% respectively. CONCLUSIONS: Our
data suggest that fractional absorption from a dietary level dose of 26Al
is about 0.13%. Compartmentalization occurs in transferrin-dependent target
tissues such as liver and spleen; however, in quantitative terms
extracellular deposition in bone is more important. Uraemia has a
significant effect on the intestinal absorption and compartmentalization of
aluminium. It enhances fractional absorption and increases subsequent
extracellular deposition of aluminium in bone. However, at the same time
uraemia does not increase transferrin-dependent cellular accumulation of
aluminium in liver and spleen.
相似文献